Glossary
List of acronyms
| AD | auto-disable syringe |
| AFR | Member States belonging to the WHO African Region |
| AFRO | WHO Regional Office for Africa |
| AFP | acute flaccid paralysis |
| AMR | Member States belonging to the WHO Region of the Americas |
| AMRO | WHO Regional Office for the Americas |
| aP | acellular pertussis vaccine |
| BCG | bacille Calmette-Guérin (vaccine against tuberculosis) |
| CBAW | childbearing aged women |
| CI | core indicator |
| CRS | congenital rubella syndrome |
| DHS | Demographic and Health Survey |
| Dip | diphtheria vaccine |
| DT | diphtheria and tetanus toxoid vaccine |
| DTaP | diphtheria and tetanus toxoid with acellular pertussis vaccine |
| DTP | diphtheria-tetanus-pertussis vaccine |
| DTP3 | third dose of diphtheria-tetanus-pertussis vaccine |
| DTPHep | Tetravalent diphtheria and tetanus toxoid with pertussis and hepatitis B vaccine |
| DTPHepIPV | pentavalent diphtheria and tetanus toxoid with pertussis, hepatitis B and inactivated polio vaccine |
| DTPHib | tetravalent diphtheria and tetanus toxoid with pertussis and Hæmophilus influenzæ type b vaccine |
| DTPHibHep | pentavalent diphtheria and tetanus toxoid with pertussis, Hæmophilus influenzæ type b and hepatitis B vaccine |
| DTPHibHepIPV | hexavalent diphtheria, tetanus toxoid with pertussis, Hæmophilus influenzæ type b, hepatitis B and inactivated polio vaccine |
| DTPHibIPV | pentavalent diphtheria and tetanus toxoid with pertussis, Hæmophilus influenzæ type b and inactivated polio vaccine |
| DTPHH | diphtheria and tetanus toxoid with pertussis, hepatitis B, and Hæmophilus influenzæ type b vaccine |
| DTwP | diphtheria and tetanus toxoid with whole cell pertussis vaccine |
| EMR | Member States belonging to the WHO Eastern Mediterranean Region |
| EMRO | WHO Regional Office for the Eastern Mediterranean |
| EPI | Expanded Programme on Immunization 30 cluster survey |
| EU | european union |
| EUR | Member States belonging to the WHO European Region |
| EURO | WHO Regional Office for Europe |
| GAVI | Global Alliance for Vaccines and Immunization |
| GNI | gross national income |
| GNP | gross national product |
| GDP | gross domestic product |
| HbsAg | hepatitis B surface antigen |
| HBV | hepatitis B virus |
| HepA | hepatitis A vaccine |
| HepAHeb | hepatitis A and Hepatitis B vaccine |
| HepB | hepatitis B vaccine |
| HepB3 | third dose of hepatitis B vaccine |
| Hib | Hæmophilus influenzæ type b vaccine |
| Hib3 | third dose of Hæmophilus influenzæ type b vaccine |
| HibHepB | Hæmophilus influenza type b and Hepatitis B vaccine |
| HibMenC | Hæmophilus influenza type b and meningococcal C vaccine |
| HPV | human papillomavirus vaccine |
| ICC | inter-agency coordinating committee |
| IPV | inactivated polio vaccine |
| IVB | WHO's Department of Immunization, Vaccines and Biologicals |
| JapEnc | japanese encephalitis vaccine |
| JE | japanese encephalitis |
| MCV | measles-containing vaccine |
| MCV1 | first dose of measles-containing vaccine |
| MCV2 | second dose of measles-containing vaccine |
| Men A | meningococcal A |
| Men AC | meningococcal AC |
| Men ACW | meningococcal ACW |
| Men ACWY | meningococcal ACWY |
| MenBC | meningococcal B and C vaccine |
| MenC conj | meningococcal C conjugate vaccine |
| MICS | Multiple Indicator Cluster Survey |
| MM | measles and mumps vaccine |
| MMR | measles, mumps, and rubella vaccine |
| MMRV | measles, mumps, rubella and varicella vaccine |
| MNT | maternal and neonatal tetanus |
| MR | measles and rubella vaccine |
| MYP | multi-year plan |
| NDP | national drug policy |
| NT | neonatal tetanus |
| OPV | oral polio vaccine |
| OPV3 | third dose of oral polio vaccine |
| Pa | acellular pertussis vaccine |
| Pneumo_conj | pneumocococal conjugate vaccine |
| Pneumo_ps | pneumocococal polysaccharide vaccine |
| PAB | protection at birth |
| POL3 | third dose of polio vaccine |
| PPP | purchasing power parity |
| Pw | whole cell pertussis vaccine |
| SEAR | Member States belonging to the WHO South-East Asia Region |
| SEARO | WHO Regional Office for South-East Asia |
| SIA | supplementary immunization activity |
| TBE | tick-borne encephalitis |
| Td | tetanus toxoid with reduced amount of diphtheria toxoid vaccine |
| Tdap | tetanus toxoid with reduced amount of diphtheria toxoid and acelullar pertussis vaccine |
| TdIPV | tetanus toxoid with reduced amount of diphtheria toxoid and inactived polio vaccine |
| TdPIPV | tetanus toxoid with reduced amount of diphtheria toxoid and pertussis and inactivated polio vaccine |
| TT | tetanus toxoid vaccine |
| TT2plus | second and subsequent doses of tetanus toxoid |
| TyphoidHepA | typhoid fever and hepatitis A vaccine |
| UNICEF | United Nations Children’s Fund |
| VAD | vitamin A deficiency |
| VF | Vaccine Fund |
| VitaminA1 | first dose of vitamin A supplement |
| VitaminA2 | second dose of vitamin A supplement |
| VPD | vaccine-preventable diseases |
| WHO | World Health Organization |
| wP | whole cell pertussis vaccine |
| WPR | Member States belonging to the WHO Western Pacific Region |
| WPRO | WHO Regional Office for the Western Pacific |
| YFV | yellow fever vaccine |
